查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1499492

Dydrogesterone市场：按类型、按应用划分 - 2024-2030 年全球预测

Dydrogesterone Market by Type (Dydrogesterone D5, Dydrogesterone D6), Application (Gynecological Diseases, Infertility) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年Dydrogesterone市场规模为5.6786亿美元，2024年将达6.1812亿美元，预计2030年将达到10.69亿美元，复合年增长率为9.45%。

Dydrogesterone是一种合成激素，其化学结构和药理作用与内源性黄体酮相似。它被归类为孕激素，是一种用来模仿天然激素孕酮作用的药物。Dydrogesterone具有很强的黄体素作用，因此非常适合黄体素缺乏症。它经常用于各种临床环境，包括月经失调、黄体功能障碍引起的不孕症以及针对更年期症状的荷尔蒙补充疗法(HRT)。与其他合成黄体素药物不同，Dydrogesterone在治疗剂量下不会抑制排卵，因此当需要维持排卵週期时，它是首选。由于女性人口老化的加剧、生殖健康问题的普遍存在、医疗基础设施的改善、医疗的进步以及政府对妇女健康的支持政策，Dydrogesterone市场正在见证成长。儘管成长前景良好，但严格的药品核准法规、副作用和市场竞争等挑战正在阻碍市场扩张。然而，开拓新的药物输送机制、引入具有成本效益的学名药以及针对广泛治疗应用的联合治疗的研究为未来的市场成长提供了利润丰厚的机会。

主要市场统计
基准年[2023] 56786万美元
预测年份 [2024] 61812万美元
预测年份 [2030] 10.69亿美元
复合年增长率（%） 9.45%

区域洞察

美洲地Dydrogesterone市场呈现稳定的成长格局。人们对妇女健康问题的认识不断提高，以及女性群体中子宫内膜异位症和月经等疾病的流行，增加了对荷尔蒙相关治疗方案的需求。由于其完善的医疗保健基础设施、大型製药公司的存在以及支持性的法律规范，美国对该地区的市场成长做出了重大贡献。除此之外，此类药物的高购买力和保险覆盖范围正在支持地Dydrogesterone市场的强劲发展。由于荷尔蒙补充疗法的广泛接受和有利的医疗保健报销政策，欧洲是欧洲/中东/非洲地Dydrogesterone市场的主要贡献者。该地区成熟的医疗保健体係有助于其强大的市场地位。另一方面，中东和非洲地区由于医疗投资的增加和妇女生殖健康意识的逐渐普及，儘管其成长率低于欧洲，但仍显示出成长潜力。亚太地区的Dydrogesterone市场预计成长率最高。推动这种扩张的因素包括妇科疾病发病率上升、劳动力中女性人数的增加、医疗基础设施的改善以及对妇女健康问题的认识提高。尤其是中国和印度等国家的医药产业正在快速成长，这些国家由于人口众多且医疗旅游不断增加而成为巨大的市场。

FPNV定位矩阵

FPNV 定位矩阵对于评估地Dydrogesterone市场供应商定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对地Dydrogesterone市场供应商的当前状态进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对Dydrogesterone市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 女性人口老化加剧和生殖健康问题普遍存在
      • 支持妇女健康的政府政策
      • 改善整个经济领域的医疗基础设施
    • 抑制因素
      • 生产地Dydrogesterone的成本很高。
    • 机会
      • 学名药核准增加
      • 市场参与企业增加投资和扩张
    • 任务
      • 与Dydrogesterone药物相关的严格监管核准流程
  • 市场区隔分析
    • 类型：DydrogesteroneD6在高精度分析和临床试验的优势
    • 用途：Dydrogesterone在妇科疾病症状缓解和荷尔蒙调节的重要应用
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章Dydrogesterone市场：依类型

  • DydrogesteroneD5
  • DydrogesteroneD6

第七章Dydrogesterone市场：依应用分类

  • 妇科疾病
  • 不孕症

第八章美洲地Dydrogesterone市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区Dydrogesterone市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲地Dydrogesterone市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 市场占有率分析（2023）
  • FPNV定位矩阵（2023）
  • 竞争情境分析
    • Theramex 宣布同意从 Viatris 收购 Duphaston 和 Femoston 的欧洲权利
    • Aurisco的Auxiton（Dydrogesterone）获得中国首个学名药核准
    • 美国製药大厂申请发布改良版药物，用于治疗子宫内膜异位症引起的骨盆腔疼痛
  • 战略分析和建议

第12章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-144C638C9216

[189 Pages Report] The Dydrogesterone Market size was estimated at USD 567.86 million in 2023 and expected to reach USD 618.12 million in 2024, at a CAGR 9.45% to reach USD 1,069.00 million by 2030.

Dydrogesterone is a synthetic hormone similar in chemical structure and pharmacological effect to endogenous progesterone. It is classified as a progestin, which is a type of medication used to replicate the effects of the natural hormone progesterone. Dydrogesterone possesses a strong progestational effect, which makes it highly suitable for conditions related to progesterone deficiency. It is frequently employed in a variety of clinical situations, such as menstrual disorders, infertility owing to luteal insufficiency, and as part of hormone replacement therapy (HRT) for menopausal symptoms. Unlike some other synthetic progestins, dydrogesterone does not inhibit ovulation at therapeutic doses, making it a preferred option in cases where maintenance of ovulatory cycles is desired. The dydrogesterone market is exhibiting growth with an increasing elderly female population and prevalence of reproductive health issues, improved healthcare infrastructure, medical advancements, and supportive government policies for women's health. Despite the growth prospects, challenges such as stringent drug approval regulations, side effects, and competitive alternatives for dydrogesterone hinder the scope of the market. However, developing novel drug delivery mechanisms, introducing generic versions for cost-effectiveness, and investigating combination therapies for broader therapeutic applications present lucrative opportunities for future market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 567.86 million
Estimated Year [2024] USD 618.12 million
Forecast Year [2030] USD 1,069.00 million
CAGR (%) 9.45%

Regional Insights

The dydrogesterone market in the Americas is experiencing a steady growth pattern. The increase in awareness regarding women's health issues and the prevalence of conditions, including endometriosis and irregular menstrual cycles in the female population, bolster the demand for hormone-related treatment options. The United States is a significant contributor to market growth within this region owing to the well-established healthcare infrastructure, presence of major pharmaceutical companies, and supportive regulatory framework. This is coupled with a higher purchasing power and insurance coverage for such medications, aiding in the positive trajectory of the dydrogesterone market. Europe is a major contributor to the dydrogesterone market in the EMEA, with widespread acceptance of hormone replacement therapies and favorable healthcare reimbursement policies. The region's mature healthcare systems contribute to its strong market position. Meanwhile, the Middle East and Africa regions show potential for growth, albeit at a slower rate compared to Europe, due to increasing healthcare investments and the gradual spread of awareness regarding women's reproductive health. The market for dydrogesterone in the Asia-Pacific region is expected to experience the highest growth rate. Factors fueling this expansion include the rising incidence of gynecological disorders, an increase in the female working population, improving healthcare infrastructure, and growing awareness around women's health issues. Particularly, countries including China and India have burgeoning pharmaceutical sectors and represent considerable markets owing to their large populations and increasing medical tourism.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Dydrogesterone Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing elderly female population and prevalence of reproductive health issues
      • Supportive government policies for women's health
      • Improved healthcare infrastructure across economies
    • Market Restraints
      • High costs associated with dydrogesterone production
    • Market Opportunities
      • Rising approval of generic dydrogesterone drugs
      • Growing investment and expansion by market players
    • Market Challenges
      • Stringent regulatory approval processes associated with dydrogesterone drugs
  • Market Segmentation Analysis
    • Type: Benefits of dydrogesterone d6 in highly precise analytical and clinical tests
    • Application: Significant applications of dydrogesterone for symptomatic relief and hormonal regulation in gynecological conditions
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Dydrogesterone Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Dydrogesterone Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Theramex Announces Agreement to Acquire the European Rights to Duphaston and Femoston From Viatris, Inc.

Theramex, a UK-based pharmaceutical company, has recently acquired rights for Duphaston (dydrogesterone) and Femoston (estradiol + dydrogesterone) from Viatris, Inc. across European markets. This strategic move, subject to regulatory and anti-trust clearances, aligns with Theramex's focus on women's health. [Published On: 2023-10-02]

Aurisco Gets Auxiton (Dydrogesterone) as First Generic Approval in China

Aurisco Pharmaceutical received China's NMPA Marketing Authorization Approval for Auxiton, a dydrogesterone oral dosage form, signaling its commitment to advancing women's health. The superior bioavailability and efficacy of Auxiton demonstrate Aurisco's focus on providing reliable luteal support for pregnancy and IVF treatments. [Published On: 2023-06-27]

US Pharma Giant Applies for Nod to Launch Tweaked Version of Drug for Pelvic Pain in Endometriosis

Abbott Laboratories is aiming to introduce an advanced dydrogesterone formulation to the Indian market, designed specifically for alleviating pelvic pain associated with endometriosis, affecting approximately 25 million women in India. On May 18, Abbott moved a step closer by applying to the Drugs Controller General of India (DCGI) for the requisite permissions to commence manufacturing and marketing the new 20 mg modified release dydrogesterone tablets, aligning with India's new drug and clinical trial regulations. This progressive variant aims to enhance the quality of life for those coping with this prevalent condition where endometrial-like tissue proliferates outside the uterine cavity. [Published On: 2023-05-20]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Dydrogesterone Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Dydrogesterone Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adalvo Limited, Alembic Pharmaceuticals Limited, Axios Research, Clearsynth, Dr. D Pharma, Gufic Group, H & Care Incorp, Jagsonpal Pharmaceuticals Ltd., Mankind Pharma Limited, Medley Pharmaceuticals Ltd., Merck KGaA, Sandoo Pharmaceuticals and Chemcials Co.,Ltd., Santa Cruz Biotechnology, Inc., Simson Pharma Limited, Solitaire Pharmacia Private Limited, Somacare, Synokem Pharmaceuticals Ltd., Taj Pharmaceuticals Limited, Theramex, TLC Pharmaceutical Standards Ltd., Viatris Inc., VIVAN Life Sciences, and Zuventus Healthcare Limited.

Market Segmentation & Coverage

This research report categorizes the Dydrogesterone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Dydrogesterone D5
    • Dydrogesterone D6
  • Application
    • Gynecological Diseases
    • Infertility
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing elderly female population and prevalence of reproductive health issues
      • 5.1.1.2. Supportive government policies for women's health
      • 5.1.1.3. Improved healthcare infrastructure across economies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with dydrogesterone production
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising approval of generic dydrogesterone drugs
      • 5.1.3.2. Growing investment and expansion by market players
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory approval processes associated with dydrogesterone drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Benefits of dydrogesterone d6 in highly precise analytical and clinical tests
    • 5.2.2. Application: Significant applications of dydrogesterone for symptomatic relief and hormonal regulation in gynecological conditions
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Dydrogesterone Market, by Type

  • 6.1. Introduction
  • 6.2. Dydrogesterone D5
  • 6.3. Dydrogesterone D6

7. Dydrogesterone Market, by Application

  • 7.1. Introduction
  • 7.2. Gynecological Diseases
  • 7.3. Infertility

8. Americas Dydrogesterone Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Dydrogesterone Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Dydrogesterone Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Theramex Announces Agreement to Acquire the European Rights to Duphaston and Femoston From Viatris, Inc.
    • 11.3.2. Aurisco Gets Auxiton (Dydrogesterone) as First Generic Approval in China
    • 11.3.3. US Pharma Giant Applies for Nod to Launch Tweaked Version of Drug for Pelvic Pain in Endometriosis
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. DYDROGESTERONE MARKET RESEARCH PROCESS
  • FIGURE 2. DYDROGESTERONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DYDROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DYDROGESTERONE MARKET DYNAMICS
  • FIGURE 7. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DYDROGESTERONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DYDROGESTERONE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DYDROGESTERONE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D5, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D5, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D6, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D6, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DYDROGESTERONE MARKET SIZE, BY GYNECOLOGICAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DYDROGESTERONE MARKET SIZE, BY GYNECOLOGICAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DYDROGESTERONE MARKET SIZE, BY INFERTILITY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DYDROGESTERONE MARKET SIZE, BY INFERTILITY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. AMERICAS DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 20. AMERICAS DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 21. AMERICAS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 22. AMERICAS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 23. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 24. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 26. ARGENTINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 28. ARGENTINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 29. BRAZIL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 30. BRAZIL DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 31. BRAZIL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 32. BRAZIL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 33. CANADA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. CANADA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. CANADA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. CANADA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. MEXICO DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. MEXICO DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. MEXICO DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. MEXICO DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. UNITED STATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 42. UNITED STATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 44. UNITED STATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 46. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. CHINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. CHINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. CHINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. CHINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. INDIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. INDIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. INDIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. INDIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. INDONESIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. INDONESIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. INDONESIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. INDONESIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. JAPAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. JAPAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. JAPAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. JAPAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. MALAYSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. MALAYSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. SINGAPORE DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. SINGAPORE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. TAIWAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. TAIWAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. TAIWAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. TAIWAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. THAILAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. THAILAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. THAILAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. THAILAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. VIETNAM DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. VIETNAM DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. VIETNAM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. VIETNAM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 107. DENMARK DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. DENMARK DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. DENMARK DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. DENMARK DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. EGYPT DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. EGYPT DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. EGYPT DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. EGYPT DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. FINLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. FINLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. FINLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. FINLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. FRANCE DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. FRANCE DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. FRANCE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. FRANCE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. GERMANY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. GERMANY DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. GERMANY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. GERMANY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. ISRAEL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. ISRAEL DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. ISRAEL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. ISRAEL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. ITALY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. ITALY DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. ITALY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. ITALY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. NIGERIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. NIGERIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. NIGERIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. NIGERIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. NORWAY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. NORWAY DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. NORWAY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. NORWAY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. POLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. POLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. POLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. POLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. QATAR DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. QATAR DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. QATAR DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. QATAR DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. RUSSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. RUSSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. RUSSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. RUSSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. SPAIN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. SPAIN DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. SPAIN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. SPAIN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. SWEDEN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. SWEDEN DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. SWEDEN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. SWEDEN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. TURKEY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. TURKEY DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. TURKEY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. TURKEY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023